Next Issue
Volume 14, 12
Previous Issue
Volume 14, 10
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
0.4
Journals
Cardiovascular Medicine
Volume 14
Issue 11
cardiovascmed-logo

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 14, Issue 11 (11 2011) – 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
2 pages, 229 KB  
Letter
Werbung mit Ungeschicktem «Wording»
by Jean-Luc Lemercier, Volkhard Göber, Christoph Huber and Thierry Carrel
Cardiovasc. Med. 2011, 14(11), 331; https://doi.org/10.4414/cvm.2011.01624 - 23 Nov 2011
Viewed by 15
Abstract
Wir nehmen Bezug auf die Werbung der Firma Edwards Lifesciences «20% Reduktion der allgemeinen Sterblichkeit bei Risikopatienten mit Aortenstenose» in der Zeitschrift «Cardiovascular Medicine. 2011;14(6):197» und können diese nicht unkommentiert lassen [...] Full article
2 pages, 780 KB  
Editorial
European Heart Journal: Impact Factor of over 10 for the First Time in Its History
by Thomas F. Lüscher
Cardiovasc. Med. 2011, 14(11), 329; https://doi.org/10.4414/cvm.2011.01621 - 23 Nov 2011
Viewed by 13
Abstract
The European Heart Journal is the official Journal of the European Society of Cardiology, one of the largest medical societies with more than 40 member states and over 45 000 members [...] Full article
2 pages, 526 KB  
Interesting Images
Phantom Tumour of the Lung
by Thomas Sebastian Gilhofer and Lars C. Huber
Cardiovasc. Med. 2011, 14(11), 327; https://doi.org/10.4414/cvm.2011.01625 - 23 Nov 2011
Cited by 1 | Viewed by 15
Abstract
Case report. A 87-year-old woman was admitted to our emergency department with p rogredient exertional dyspnoea [...] Full article
2 pages, 778 KB  
Interesting Images
Neo Snowman in X-Ray
by Arunkumar Panneerselvam, Rajiv Ananthakrishna, Prabhavathi Bhat and Manjunath C Nanjappa
Cardiovasc. Med. 2011, 14(11), 325; https://doi.org/10.4414/cvm.2011.01626 - 23 Nov 2011
Viewed by 14
Abstract
Case report. A 63-year-old hypertensive male presented with atypical chest discomfort and breathlessness on exertion [...] Full article
10 pages, 1170 KB  
Editorial
How to Transform You into a Radialist: Tips and Tricks
by Caroline Frangos and Stéphane Noble
Cardiovasc. Med. 2011, 14(11), 315; https://doi.org/10.4414/cvm.2011.01620 - 23 Nov 2011
Cited by 4 | Viewed by 11
Abstract
The transradial approach increases patient comfort and reduces vascular complications and major bleeding. Although modern equipment has been improved and catheter sizes reduced, there remain specific technical challenges in the practice of the transradial approach. Indeed, the transradial approach requires a longer learning [...] Read more.
The transradial approach increases patient comfort and reduces vascular complications and major bleeding. Although modern equipment has been improved and catheter sizes reduced, there remain specific technical challenges in the practice of the transradial approach. Indeed, the transradial approach requires a longer learning curve than transfemoral access, but the transradial challenges are usually overcome with experience. Nowadays, in view of its benefits, there is no longer any justification for ignoring the transradial approach, the patient’s preferred access route for percutaneous coronary interventions. In this paper we highlight five rules which will transform you into a radialist and provide valuable tips and tricks. Full article
12 pages, 1592 KB  
Review
Die Arrhythmogene Rechtsventrikuläre Dysplasie/Kardiomyopathie
by Ardan M. Saguner, Corinna Brunckhorst and Firat Duru
Cardiovasc. Med. 2011, 14(11), 303; https://doi.org/10.4414/cvm.2011.01623 - 23 Nov 2011
Viewed by 11
Abstract
arrhythmogenic right ventricular dysplasia/cardiomyopathy: an underrecognised disease? Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited myocardial disease that may lead to sudden cardiac death (SCD) and progressive heart failure. Genetic studies have identified causative mutations in genes encoding desmosomal proteins that reduce the [...] Read more.
arrhythmogenic right ventricular dysplasia/cardiomyopathy: an underrecognised disease? Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited myocardial disease that may lead to sudden cardiac death (SCD) and progressive heart failure. Genetic studies have identified causative mutations in genes encoding desmosomal proteins that reduce the stability of the myocardial structure. Thus, ARVD/C is regarded as a genetically determined myocardial dystrophy. The term “right ventricular” is misleading, as in up to 50% of the cases, the left ventricle is also involved and a broader term such as “arrhythmogenic cardiomyopathy” may be preferred. Since the modification of the original 1994 Task Force criteria by W. McKenna and colleagues in 2010, the diagnosis is established according to the “Revised Task Force Criteria”. These include imaging techniques demonstrating functional a nd structural changes of the right ventricle, fibrous replacement of myocardium through biopsy, electrocardiogram depolarisation and repolarisation abnormalities, ventricular arrhythmias and a positive family history including identification of pathogenic genetic mutations. This approach s hall increase sensitivity for early diagnosis without loosing specificity. Several risk factors for SCD such as syncope, certain mutations and young age at manifestation have been identified, although risk stratification still needs improvement, especially in oligosymptomatic patients. Therapeutic strategies include restriction from strenuous physical exercise, antiarrhythmic drugs such as betablockers, sotalol and amiodarone and implantable cardioverter defibrillators. Life-long follow-up is warranted in asymptomatic carriers of pathogenic mutations due to differences in age-related penetrance. Given the clinical relevance of this underrecognised disease, we have established a research and clinical program with focus on ARVD/C at the Clinic for Cardiology of the University Hospital Zurich. Full article
1 pages, 641 KB  
Review
New Frontiers in Exercise Training and Testing
by Jean-Paul Schmid
Cardiovasc. Med. 2011, 14(11), 229; https://doi.org/10.4414/cvm.2011.01622 - 23 Nov 2011
Viewed by 13
Abstract
In the last few years, several new concepts concerning exercise training and prescription in cardiac patients have emerged and new guidelines have been published. The general trend goes in the direction of more intensive exercise training to optimise its effect. Thereby, the focus [...] Read more.
In the last few years, several new concepts concerning exercise training and prescription in cardiac patients have emerged and new guidelines have been published. The general trend goes in the direction of more intensive exercise training to optimise its effect. Thereby, the focus is not only on improvement in exercise capacity, but also on structural changes of the myocardium and optimal weight loss. This review addresses practical aspects of these new concepts. Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-7
Previous Issue
Next Issue
Back to TopTop